David Boberski is managing director, OTC Research and New Product Development, at the CME Group. He was named to that position on February 26, 2009. He will be responsible for identifying and developing new product opportunities in credit and interest rates, adapting existing CME Group products and services to the over-the-counter (OTC) markets and educating CME Group customers on CME Group credit and interest rate products. He reports to Julie Winkler, Managing Director, Research and Product Development.
Before joining CME Group, Boberski worked as a consulting expert for the U.S. Commodity Futures Trading Commission's Division of Enforcement. He also has served as Executive Director and Head of Exchange Traded Derivatives Research for UBS Investment Bank and Managing Director, Principal and Head of Interest Rate Strategy for Bear, Stearns and Co.. He also worked as an Adjunct Professor in Portfolio Theory Economics at the University of Illinois.
He has published two books and has been named to the Institutional Investor All-American Research Team. He is a Series 3, 7, 16 and 63 Registered Representative.
Boberski earned bachelor's degrees in economics and finance from the College of William and Mary, a master's degree in economics from the University of Chicago and a master's degree in finance from the University of Illinois.
JLN News Feed
Delisting of Securities of KemPharm, Inc.; Endologix, Inc.; VIVUS, Inc.; SAExploration Holdings, Inc.; Ascena Retail Group, Inc.; and Global Eagle Entertainment Inc. from The Nasdaq Stock Market
DTCC Comments on Senate Confirmation of Hester Peirce and Caroline Crenshaw as Commissioners to the SEC
We visit more than 100 websites daily for financial news (Would YOU do that?). Read the John Lothian Newsletter.